ARMP vs. ABUS

Last updated Jun 3, 2026

ARMP (Armata Pharmaceuticals Inc.) and ABUS (Arbutus Biopharma Corporation) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, ARMP returned -30.20%/yr vs 0.76%/yr for ABUS. At a 0.06 correlation, their price movements are largely independent.

Performance

ARMP vs. ABUS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Armata Pharmaceuticals Inc. (ARMP) and Arbutus Biopharma Corporation (ABUS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ARMP achieves a 26.11% return, which is significantly higher than ABUS's -11.43% return. Over the past 10 years, ARMP has underperformed ABUS with an annualized return of -30.20%, while ABUS has yielded a comparatively higher 0.76% annualized return.

ARMP

• 1D: 1.54%
• 1M: -10.91%
• YTD: 26.11%
• 6M: 49.15%
• 1Y: 308.25%
• 3Y*: 70.07%
• 5Y*: 13.80%
• 10Y*: -30.20%

ABUS

• 1D: -4.91%
• 1M: -1.39%
• YTD: -11.43%
• 6M: 2.16%
• 1Y: 26.79%
• 3Y*: 18.19%
• 5Y*: 7.63%
• 10Y*: 0.76%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ARMP vs. ABUS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ARMP Armata Pharmaceuticals Inc.	26.11%	239.46%	-42.90%	161.29%	-77.37%	83.59%	-8.16%	12.53%	-79.57%	-77.05%
ABUS Arbutus Biopharma Corporation	-11.43%	47.09%	30.80%	7.30%	-40.10%	9.58%	27.70%	-27.42%	-24.16%	106.12%

Correlation

The correlation between ARMP and ABUS is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.06
Correlation (10Y) Calculated over the trailing 10-year period	0.05
Correlation (All Time) Calculated using the full available price history since Aug 4, 2015	0.06

Fundamentals

Market Cap ARMP : $289.32M ABUS : $831.61M
EPS ARMP : -$7.79 ABUS : $0.83
PS Ratio ARMP : 65.14 ABUS : 4.29
Total Revenue (TTM) ARMP : $4.41M ABUS : $191.45M
Gross Profit (TTM) ARMP : $3.26M ABUS : $12.30M
EBITDA (TTM) ARMP : -$27.14M ABUS : $156.13M

Return for Risk

ARMP vs. ABUS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARMP

ARMP Risk / Return Rank: 92
ARMP Sharpe Ratio Rank: 89
ARMP Sortino Ratio Rank: 92
ARMP Omega Ratio Rank: 90
ARMP Calmar Ratio Rank: 93
ARMP Martin Ratio Rank: 94

ABUS

ABUS Risk / Return Rank: 59
ABUS Sharpe Ratio Rank: 60
ABUS Sortino Ratio Rank: 55
ABUS Omega Ratio Rank: 53
ABUS Calmar Ratio Rank: 62
ABUS Martin Ratio Rank: 64

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARMP vs. ABUS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Armata Pharmaceuticals Inc. (ARMP) and Arbutus Biopharma Corporation (ABUS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ARMP	ABUS	Difference
Sharpe ratio Return per unit of total volatility	2.20	0.58	+1.61
Sortino ratio Return per unit of downside risk	3.65	1.07	+2.58
Omega ratio Gain probability vs. loss probability	1.45	1.13	+0.31
Calmar ratio Return relative to maximum drawdown	6.29	1.04	+5.26
Martin ratio Return relative to average drawdown	17.21	2.62	+14.59
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ARMP vs. ABUS - Sharpe Ratio Comparison

The current ARMP Sharpe Ratio is 2.20, which is higher than the ABUS Sharpe Ratio of 0.58. The chart below compares the historical Sharpe Ratios of ARMP and ABUS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ARMP	ABUS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.20	0.58	+1.61
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.12	0.14	-0.02
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.27	0.01	-0.28
Sharpe Ratio (All Time) Calculated using the full available price history	-0.24	-0.10	-0.14

Drawdowns

ARMP vs. ABUS - Drawdown Comparison

The maximum ARMP drawdown since its inception was -99.98%, which is greater than ABUS's maximum drawdown of -92.96%. Use the drawdown chart below to compare losses from any high point for ARMP and ABUS.

Drawdown Indicators

	ARMP	ABUS	Difference
Max Drawdown Largest peak-to-trough decline	-99.98%	-92.96%	-7.02%
Max Drawdown (1Y) Largest decline over 1 year	-48.65%	-25.86%	-22.79%
Max Drawdown (3Y) Largest decline over 3 years	-79.22%	-36.84%	-42.38%
Max Drawdown (5Y) Largest decline over 5 years	-85.70%	-63.42%	-22.28%
Max Drawdown (10Y) Largest decline over 10 years	-99.69%	-92.96%	-6.73%
Current Drawdown Current decline from peak	-99.84%	-65.51%	-34.33%
Average Drawdown Average peak-to-trough decline	-82.78%	-68.77%	-14.01%
Ulcer Index Depth and duration of drawdowns from previous peaks	17.79%	10.21%	+7.58%

Volatility

ARMP vs. ABUS - Volatility Comparison

Armata Pharmaceuticals Inc. (ARMP) has a higher volatility of 23.84% compared to Arbutus Biopharma Corporation (ABUS) at 10.98%. This indicates that ARMP's price experiences larger fluctuations and is considered to be riskier than ABUS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ARMP	ABUS	Difference
Volatility (1M) Calculated over the trailing 1-month period	23.84%	10.98%	+12.86%
Volatility (6M) Calculated over the trailing 6-month period	80.43%	36.23%	+44.20%
Volatility (1Y) Calculated over the trailing 1-year period	141.42%	46.04%	+95.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	113.73%	54.93%	+58.80%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	110.47%	85.54%	+24.93%

Dividends

ARMP vs. ABUS - Dividend Comparison

Neither ARMP nor ABUS has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ARMP and ABUS in my portfolio?

ARMP and ABUS have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ARMP or ABUS?

ARMP has higher volatility (23.84%) compared to ABUS (10.98%). In terms of maximum drawdown, ARMP dropped -99.98% vs ABUS's -92.96%.

Which has better risk-adjusted returns?

ARMP currently has the higher Sharpe Ratio (2.20 vs 0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.